AstraZeneca has received approval from the FDA for its BTK inhibitor, Calquence (acalabrutinib), for first-line use in MCL.

North Chicago, Illinois-based AbbVie Inc. (ABBV) focuses on creating medicines and solutions that address complex health issues and enhance people's lives through its core therapeutic areas ...

Israel and Hamas appear close to a cease-fire deal to end more than 15 months of devastating fighting in Gaza, though it's facing something of a last-minute crisis. The agreement, which has hit a ...

Israel’s cabinet approved an agreement on a cease-fire in the Gaza Strip that would free Israeli hostages, ending two days of debate that had underscored the pact’s fragility. The full cabinet ...

Ten IDF soldiers were moderately and lightly injured in a weapons explosion on a training base in southern Israel, the IDF confirmed. The IDF reported that "three soldiers were moderately injured ...

It has been Israel’s longest war – the longest single conventional war of the entire Israeli-Palestinian conflict. In intensity and concentration of violence in the 25-mile-long Gaza Strip ...

AbbVie closed out the year on a high note as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s final monthly ranking of the biggest TV ad spenders in biopharma.

DOHA, Qatar (AP) — Israel and Hamas have agreed to pause the devastating war in the Gaza Strip, mediators announced Wednesday, raising the possibility of winding down the deadliest and most ...

Israel and Hamas have reached a ceasefire agreement that would put a stop to more than a year of fighting, according to multiple reports. A Hamas official told Sky News and several other outlets that ...

After more than 15 months in Hamas captivity, the first of an initial group of 33 hostages is expected to be returned to Israel on Sunday before negotiations on the release of the remaining 65 ...

Today, we're tracking presentations from AbbVie, UCB, WuXi AppTec and several other biopharma firms. Aside from JPM conference coverage, our reporters are making their way around town for one-on ...

The Medicare coverage story of the Cardiomems device has a Homeric air about it, spanning nearly a decade starting with an adverse local coverage determination in 2016. Abbott Park, Ill.-based Abbott ...